Found 4 matching trials
A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
PHASE1The purpose of the study is to test the safety of six cycles of cenersen tr...
Location
H. Lee Moffitt Cancer Center & Research Institute
Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course
PHASE2The purpose of this study is to assess whether treatment with cenersen in c...
Location
Multiple Locations
EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2The purpose of this research study is to see if the investigational drug EL...
Location
Duke University Medical Center
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
PHASE2The principal goal of this clinical trial is to assess the ability of cener...
Location
University of California, San Diego